Strategic Initiative

Slingshot members are tracking this corporate initiative:

Amgen (AMGN) Agrees to Strategic Collaboration with Immatics Biotechnologies GmbH to Develop T-Cell Immunotherapies for a Range of Cancers

Source Link:
http://www.prnewswire.com/news-releases/amgen-and-immatics-enter-strategic-collaboration-to-develop-novel-bispecific-cancer-immunotherapies-300387532.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AMGN
100%
Immatics Biotechnologies GmbH
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Jan 09, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2018
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords T-cell Immunotherapies
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.